IN2015DN02685A - - Google Patents

Download PDF

Info

Publication number
IN2015DN02685A
IN2015DN02685A IN2685DEN2015A IN2015DN02685A IN 2015DN02685 A IN2015DN02685 A IN 2015DN02685A IN 2685DEN2015 A IN2685DEN2015 A IN 2685DEN2015A IN 2015DN02685 A IN2015DN02685 A IN 2015DN02685A
Authority
IN
India
Prior art keywords
subject
cancer
radiation
predisposition
copd
Prior art date
Application number
Other languages
English (en)
Inventor
Diana; Anderson
Mojgan; Jafzadeh
Morgan Clive Thomas; Denyer
Original Assignee
Univ Bradford
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bradford filed Critical Univ Bradford
Publication of IN2015DN02685A publication Critical patent/IN2015DN02685A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7004—Stress
    • G01N2800/7009—Oxidative stress
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7023—(Hyper)proliferation
    • G01N2800/7028—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Ecology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IN2685DEN2015 2012-09-11 2013-09-10 IN2015DN02685A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1216174.1A GB201216174D0 (en) 2012-09-11 2012-09-11 Method of determining a predisposition to disease states characterised by free redical induced dna damage
PCT/GB2013/052365 WO2014041340A1 (en) 2012-09-11 2013-09-10 Methods of, and assay products for, determining the predisposition of a subject to disease states characterised by free radical induced dna damage

Publications (1)

Publication Number Publication Date
IN2015DN02685A true IN2015DN02685A (de) 2015-09-04

Family

ID=47137246

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2685DEN2015 IN2015DN02685A (de) 2012-09-11 2013-09-10

Country Status (7)

Country Link
US (1) US20150219619A1 (de)
EP (1) EP2895853A1 (de)
JP (1) JP2015529077A (de)
CN (1) CN104755927A (de)
GB (1) GB201216174D0 (de)
IN (1) IN2015DN02685A (de)
WO (1) WO2014041340A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9931634B2 (en) 2014-02-27 2018-04-03 The Regents Of The Univeristy Of California High throughput DNA damage quantification of human tissue with home-based collection device
KR20230120122A (ko) 2020-10-22 2023-08-16 4디 라이프텍 아게 암 및 암 감수성의 검출을 위한 새로운 바이오마커로서의 dna 손상 민감도

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2638750A1 (en) * 2006-03-02 2007-09-13 Laboratory Corporation Of America Holdings Methods and systems for evaluating health risk factors by measurement of dna damage and dna repair

Also Published As

Publication number Publication date
US20150219619A1 (en) 2015-08-06
CN104755927A (zh) 2015-07-01
JP2015529077A (ja) 2015-10-05
GB201216174D0 (en) 2012-10-24
WO2014041340A1 (en) 2014-03-20
EP2895853A1 (de) 2015-07-22

Similar Documents

Publication Publication Date Title
EA201590027A1 (ru) Способы детекции заболеваний или состояний
ZA201903597B (en) Biosensors for biological or chemical analysis and methods of manufacturing the same
WO2015094995A3 (en) Gene signature biomarkers of tumor response to pd-1 antagonists
EP3236262A3 (de) Surrogatfunktionsdiagnosetest für krebs
MX2015006680A (es) Composiciones y metodos para diagnosticar tumores de tiroides.
WO2012021887A3 (en) Biomarkers for the early detection of breast cancer
MX2018008421A (es) Métodos para tratar cáncer y el uso de biomarcadores como predictor de sensibilidad clínica a terapias.
CL2013003433A1 (es) Método para analizar una muestra biológica de un sujeto con cáncer que comprende determinar un nivel de expresión de los biomarcadores gli-1, otx-2, shroom2, pdlim3, y sphk1 en dicha muestra, en donde el nivel de expresión de los biomarcadores en coparación con un control, proporciona un indicador de diagnóstico de si el sujeto tiene una probabilidad aumentada de respuesta a: un ácido metil-4’-trifluorometoxi-bifenil-3-carboxílixo [6-(cis-2,6-dimetil-morfolino-4-il)-piridin-3-il]-amida, ó 2-[(r)-4-(6-bencil-4,5-dimetil-piridazin-3-il)-2-metil-3,4,5,6-tetrahidro-2h-[1,2’] bipirizanil-5’-il]-propan-2-ol; método para seleccionar a un sujeto que tiene cáncer para el tratamiento con uno de dichos compuestos, el cual comprende determinar el nivel de expresión de shroom2 o sphk1, en una muestra biológica del sujeto.
EP4282405A3 (de) Nachweis von krebs-biomarkern mittels nanopartikeln
WO2013107459A3 (en) Microrna for diagnosis of pancreatic cancer and/or prognosis of patients with pancreatic cancer by blood samples
GB2526736A (en) Methods, compositions, and kits for nucleic acid analysis
MY182773A (en) Method for indicating a presence or non-presence of aggressive prostate cancer
WO2013033609A3 (en) Methods and compositions for the treatment and diagnosis of cancer
WO2012149493A3 (en) Hsp90 combination therapy
WO2013172779A3 (en) Method for indicating the presence or non-presence of prostate cancer
WO2013190075A3 (en) Specific biomarkers for hepatocellular carcinoma (hcc)
MX358541B (es) Metodos para predecir el riesgo de desarrollar hipertension.
EP4321866A3 (de) Gdf-15 als diagnostischer marker zur vorhersage des klinischen ergebnisses einer behandlung mit immuncheckpoint-blockern
TR201909951T4 (tr) Kanser olduğundan şüphelenilen bir hastanın aflibersept ile tedavisinin sonucunun öngörülmesine yönelik yöntem.
WO2011112845A3 (en) Methods and compositions related to a multi-methylation assay to predict patient outcome
MX2019010935A (es) Panel de marcadores geneticos para el diagnostico de cancer colorrectal.
EP2569635A4 (de) Verfahren zur diagnose und/oder behandlung von enzephalitis oder epilepsie
NZ716643A (en) Methods for predicting the risk of having a cardiovascular event and for monitoring the treatment of a cardiovascular event
WO2011137388A3 (en) Identification and use of biomarkers for detection and quantification of the level of radiation exposure in a biological sample
EP2841926A4 (de) Probenanalysevorrichtung für biologische tests